Latest Derivatives News

NH3 Clean Energy has successfully completed the Pre-FEED engineering phase for its WAH2 clean ammonia project, unlocking new opportunities for emissions and cost optimization while preparing for strategic partnerships.

BMG Resources pushes forward with expansion drilling at its Abercromby and Bullabulling gold projects in Western Australia, supported by a recent $1.5 million capital raise. The company navigates regulatory caution by retracting prior production targets while maintaining a focus on resource growth.

Harvest Technology Group reported a robust 32% revenue increase and secured strategic partnerships to drive its path to profitability by FY27. The company also raised over $3 million through convertible notes to support expansion efforts.

Red Sky Energy's December 2024 report reveals steady production from Yarrow 3, imminent fracture stimulation at Yarrow 1, and a transformative 35% stake in Angola's Block 6/24, positioning the company for diversified growth and enhanced cash flow.

HITIQ Limited’s largest shareholder, Harmil Angel Investments, is converting $1.6 million in convertible notes into shares, while the company revamps its advisory mandate to attract US investors.

Pacific Current Group reports a 6.1% increase in total Funds Under Management to A$30 billion as of December 31, 2024, despite a decline in USD-denominated assets and exits from two boutique managers.

Pancontinental Energy reports encouraging technical progress on its PEL 87 project with improved reservoir confidence and ongoing drilling success in Namibia’s Orange Basin, underpinning a solid cash position.

EVZ Limited has issued earnings guidance for the first half of FY2025, forecasting revenue between $53 million and $55 million and EBITDA ranging from $2.4 million to $2.6 million based on preliminary figures.

OZZ Resources reports a promising scoping study for its Maguires Reward gold project, highlighting potential positive cash flow despite limited exploration activity during the December 2024 quarter.

Far East Gold Ltd has reported a maiden JORC resource estimate of 540,000 ounces of gold at its Idenburg project in Indonesia, alongside a conditional acquisition agreement and nearly A$10 million in funding from strategic investor Xingye Gold.

Amplia Therapeutics reports encouraging progress in its Phase 2a ACCENT trial for pancreatic cancer, with nine confirmed partial responses and ongoing patient recruitment. The company also strengthens its financial position with a $13 million capital raise to support further clinical development.

Cynata Therapeutics reports encouraging Phase 1 results for its diabetic foot ulcer treatment CYP-006TK, alongside a strengthened balance sheet and ongoing clinical progress.